Paula Jeffs-Gonzalez
Endocrinology, Diabetes & Metabolism · Trujillo Alto, PRNPI 1023443983
Payments from drug & device makers
Across 134 payments — averaging $30.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$998
- Boehringer Ingelheim$561
- Novo Nordisk$508
- Johnson & Johnson$388
- Sanofi-aventis U.S. LLC$344
- Medtronic$266
- plus $977 from 13 others
What the payments were for
- Food & beverage$4,041100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $998 |
| Boehringer Ingelheim | 17 | $561 |
| Novo Nordisk | 20 | $508 |
| Johnson & Johnson | 11 | $388 |
| Sanofi-aventis U.S. LLC | 17 | $344 |
| Medtronic | 3 | $266 |
| Eli Lilly Export S.A. Puerto Rico Branch | 6 | $140 |
| Merck | 7 | $125 |
| Lilly USA, LLC | 1 | $119 |
| Amgen | 2 | $117 |
| BETA Bionics, Inc. | 1 | $116 |
| Abbott | 5 | $89 |
| Bayer Puerto Rico Inc. | 3 | $71 |
| AbbVie | 3 | $46 |
| Bayer | 2 | $42 |
| Pfizer Pharmaceuticals LLC | 2 | $39 |
| PBG Puerto Rico LLC | 2 | $30 |
| Radius Health, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$457
- iLet Bionic Pancreas$347
- MINIMED 770G$127
- JARDIANCE$125
- Ozempic$125
- ZEPBOUND$119
- MINIMED 780G$119
- iLet Insulin Infusion Kit Inset$116
- iLet Insulin Infusion Kit Contact Detach$116
- Repatha$100
- INVOKANA$100
How this compares
$4,041 in reported general payments places this provider in the 40th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 579 | $570,136 |
| TrulicityDulaglutide | 516 | $511,683 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 496 | $334,377 |
| SynjardyEmpagliflozin/Metformin Hcl | 457 | $293,145 |
| JardianceEmpagliflozin | 224 | $160,172 |
| Xigduo XrDapaglifloz Propaned/Metformin | 211 | $136,530 |
| JentaduetoLinagliptin/Metformin Hcl | 180 | $102,835 |
| FarxigaDapagliflozin Propanediol | 131 | $85,856 |
| SynthroidLevothyroxine Sodium | 833 | $84,224 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 124 | $81,364 |
| GlyxambiEmpagliflozin/Linagliptin | 105 | $74,455 |
| TradjentaLinagliptin | 84 | $54,933 |
| JanumetSitagliptin Phos/Metformin Hcl | 75 | $48,066 |
| LantusInsulin Glargine,hum.Rec.Anlog | 311 | $35,859 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $24,084 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTrijardy Xr, Synjardy, Jardiance, Jentadueto, Synjardy Xr | $561 | $1,120,3041,700 claims |
| Novo NordiskOzempic | $508 | $570,136579 claims |
| Lilly USA, LLCTrulicity, Humulin 70-30, Humalog, Humalog Mix 75-25, Insulin Lispro | $119 | $543,263827 claims |
| MerckJanumet, Janumet Xr, Januvia | $125 | $86,363145 claims |
| AstraZenecaFarxiga | $998 | $85,856131 claims |
| AbbVieSynthroid | $46 | $84,224833 claims |
| Sanofi-aventis U.S. LLCLantus | $344 | $35,859311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
Other endocrinology, diabetes & metabolism in Trujillo Alto
- Angel Comulada RiveraBayamon$8.9M
- Ramon Ortiz CarrasquilloManati$6M
- Alex Gonzalez BossoloSan Juan$5.5M
- Martha GomezSan Juan$3.8M
- Paola Mansilla-LetelierBayamon$3.1M
- Altagracia Alcantara GonzalezBayamon$1M
- Myriam Allende-VigoHumacao$963K
- Jose Garcia MateoPonce$945K
- Wilfredo BravoCaguas$767K
- Michelle Mangual GarciaSan Juan$743K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.